France Reports Highly Positive Patient Response To Medical Cannabis Trial
FRANCE’s ongoing medical cannabis ‘experiment’, in which 3,000 patients are offered free products, has reported an overwhelmingly positive patient response.
FRANCE’s ongoing medical cannabis ‘experiment’, in which 3,000 patients are offered free products, has reported an overwhelmingly positive patient response.
The life of a teenager who can have hundreds of epileptic seizures a day “hangs in the balance” without cannabis treatment, his parents say.
Leafly and similar sites will be able to resume contracting with Florida medical marijuana operators to allow patients to order products online, under a ruling issued Monday by an administrative law judge.
More than 40% of patients with breast cancer reported using cannabis to manage their treatment symptoms, yet most patients did not discuss cannabis use with a physician, according to survey results published in Cancer.
Medicine produced from cannabis oils can improve patients’ quality of life, but how the country will make legal cannabis farms financially viable remains uncertain
France is Europe’s biggest cannabis consumer, despite having some of the continent’s toughest laws against the drug.
“There will be about two years of experimentation with therapeutic cannabis, beginning as soon as the health ministry gives the green light,”
The committee, convened by France’s ANSM (the French National Agency for the Safety of Medicines and Health Products), stated that it would be “appropriate to authorise the use of therapeutic cannabis
I wouldn’t advise anyone to smoke cannabis. We sell it like any other item, just like a furniture shop sells tables or chairs.”